Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
This is especially risky if you are also taking other medications for blood sugar management
Common positive reports include reduced joint stiffness and morning pain (likely primarily from weight loss), improved energy levels after initial adjustment, better mood and reduced brain fog, improved sleep quality, and feeling that their autoimmune medications "work better" than before starting tirzepatide
While patients may hope to maintain their lowest achieved weight, research suggests that maintaining a portion of initial weight loss is a more achievable long-term outcome for many individuals
It may be a fit for patients who: Struggle with frequent hunger Experience cravings or snacking patterns Have difficulty with portion control Need structured medical weight loss support Prefer a GLP-1 focused option Have a medical history that fits semaglutide therapy Tolerate GLP-1 treatment well Semaglutide may also be considered when a provider wants to begin with a more established GLP-1 pathway before considering other medication options
Users report five distinct categories of body aches while on tirzepatide treatment
Tirzepatide (Mounjaro, Zepbound) is an FDA-approved dual GIP/GLP-1 receptor agonist for type 2 diabetes and chronic weight management, while multiple sclerosis is a chronic autoimmune disorder affecting the central nervous system
